Product Description
Product Name: Velpatasvir & Sofosbuvir Tablets
Composition: Velpatasvir 100 mg + Sofosbuvir 400 mg
Form: Oral Tablet
Category: Direct-Acting Antiviral (DAA) Combination
Indication: Chronic Hepatitis C Virus (HCV) Infection – Genotypes 1 through 6
Velpatasvir & Sofosbuvir Tablets is a fixed-dose combination antiviral medication used for the treatment of chronic Hepatitis C virus (HCV) infection across all major genotypes (1–6). This all-oral, once-daily therapy offers a pan-genotypic cure, with high sustained virologic response (SVR) rates, making it one of the most effective treatment options available.
